Overview

CSPPT- Chronic Kidney Diseases Study

Status:
Withdrawn
Trial end date:
2014-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this trial is to confirm that enalapril maleate and folic acid tablets is more effective in preventing renal function decline among the patients with primary hypertension when compared to enalapril maleate.
Phase:
Phase 4
Details
Lead Sponsor:
Shenzhen Ausa Pharmed Co.,Ltd
Collaborator:
Nanfang Hospital of Southern Medical University
Treatments:
Enalapril
Enalaprilat
Folic Acid
Maleic acid
Vitamin B Complex